West Palm Beach, FL – Today, Representative Lois Frankel (FL-22) released the following statement on the decision in the case Alliance for Hippocratic Medicine v. FDA, in which Judge Matthew Kacsmaryk has stayed FDA approval of mifepristone—which studies have proven to be safe and effective, and is currently used in over half of abortions. The stay would go into effect in 7 days.

The district court decision by Judge Kacsmaryk—who was nominated by former President Donald Trump and confirmed on a party-line vote in 2019—blocks access to mifepristone in 7 days, pending an appeal to the decision.

“Today, one man, in one district court, issued a decision that ignores 20 years of science and expertise at the FDA in an attempt to block access to mifepristone, a safe and effective form of medication abortion. This decision is not only downright dangerous to the millions of women who could lose access to abortion care without mifepristone—it’s also an attack on the authority of the FDA,” said Rep. Frankel.

“We are not going to sit back and let one man have the final word on women’s access to medication abortion. We will keep fighting to ensure that access to mifepristone, and all medication, is based on science, not ideology—and that women’s health care decisions are between her and her doctor, not politicians.”

###